These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 16951564)

  • 1. White matter abnormalities in dystonia normalize after botulinum toxin treatment.
    Blood AJ; Tuch DS; Makris N; Makhlouf ML; Sudarsky LR; Sharma N
    Neuroreport; 2006 Aug; 17(12):1251-5. PubMed ID: 16951564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum toxin modulates basal ganglia but not deficient somatosensory activation in orofacial dystonia.
    Dresel C; Bayer F; Castrop F; Rimpau C; Zimmer C; Haslinger B
    Mov Disord; 2011 Jul; 26(8):1496-502. PubMed ID: 21604301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Craniocervical dystonia: clinical and pathophysiological features.
    Colosimo C; Suppa A; Fabbrini G; Bologna M; Berardelli A
    Eur J Neurol; 2010 Jul; 17 Suppl 1():15-21. PubMed ID: 20590803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum toxin treatment of occupational and focal hand dystonia.
    Karp BI
    Mov Disord; 2004 Mar; 19 Suppl 8():S116-9. PubMed ID: 15027063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restoring balance in focal limb dystonia with botulinum toxin.
    Sheean G
    Disabil Rehabil; 2007 Dec; 29(23):1778-88. PubMed ID: 18033603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Focal dystonia: the role of botulinum toxin.
    Tintner R; Jankovic J
    Curr Neurol Neurosci Rep; 2001 Jul; 1(4):337-45. PubMed ID: 11898539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dystonia in Machado-Joseph disease: Clinical profile, therapy and anatomical basis.
    Nunes MB; Martinez AR; Rezende TJ; Friedman JH; Lopes-Cendes I; D'Abreu A; França MC
    Parkinsonism Relat Disord; 2015 Dec; 21(12):1441-7. PubMed ID: 26552869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Secondary focal dystonia].
    Deligny C; Raoul S; de Ferron E; Auffray E; Guillon B
    Rev Neurol (Paris); 2004 Oct; 160(10):983-5. PubMed ID: 15492727
    [No Abstract]   [Full Text] [Related]  

  • 9. Severe tongue protrusion dystonia: clinical syndromes and possible treatment.
    Schneider SA; Aggarwal A; Bhatt M; Dupont E; Tisch S; Limousin P; Lee P; Quinn N; Bhatia KP
    Neurology; 2006 Sep; 67(6):940-3. PubMed ID: 17000958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Botulinum toxin therapy: from dreaded biological toxin to standard pharmaceutical].
    Schnider P; Voller B; Moraru K; Auff E
    Wien Klin Wochenschr; 1999 Oct; 111(20):825-9. PubMed ID: 10586486
    [No Abstract]   [Full Text] [Related]  

  • 11. Delayed-onset focal dystonia of the leg secondary to traumatic brain injury.
    Kemp S; Kim SD; Cordato DJ; Fung VS
    J Clin Neurosci; 2012 Jun; 19(6):916-7. PubMed ID: 22341145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Task-free functional MRI in cervical dystonia reveals multi-network changes that partially normalize with botulinum toxin.
    Delnooz CC; Pasman JW; Beckmann CF; van de Warrenburg BP
    PLoS One; 2013; 8(5):e62877. PubMed ID: 23650536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum toxin therapy of writer's cramp.
    Das CP; Dressler D; Hallett M
    Eur J Neurol; 2006 Feb; 13 Suppl 1():55-9. PubMed ID: 16417599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dystonias and botulinum toxin.
    Khadilkar SV
    J Assoc Physicians India; 2003 May; 51():443-4. PubMed ID: 12974422
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-term follow-up of botulinum toxin therapy for focal hand dystonia: outcome at 10 years or more.
    Lungu C; Karp BI; Alter K; Zolbrod R; Hallett M
    Mov Disord; 2011 Mar; 26(4):750-3. PubMed ID: 21506157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors predicting improvement in motor disability in writer's cramp treated with botulinum toxin.
    Djebbari R; du Montcel ST; Sangla S; Vidal JS; Gallouedec G; Vidailhet M
    J Neurol Neurosurg Psychiatry; 2004 Dec; 75(12):1688-91. PubMed ID: 15548483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum toxin therapy of laryngeal muscle hyperactivity syndromes: comparing different botulinum toxin preparations.
    Truong DD; Bhidayasiri R
    Eur J Neurol; 2006 Feb; 13 Suppl 1():36-41. PubMed ID: 16417596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical profile of various sub-types of writer's cramp.
    Das CP; Prabhakar S; Truong D
    Parkinsonism Relat Disord; 2007 Oct; 13(7):421-4. PubMed ID: 17400019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temporomandibular disorders in patients with craniocervical dystonia.
    Costa AL; Campos LS; França MC; D'Abreu A
    Arq Neuropsiquiatr; 2011 Dec; 69(6):896-9. PubMed ID: 22297875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative treatment with botulinum toxin to facilitate cervical fusion in dystonic cerebral palsy. Report of two cases.
    Racette BA; Lauryssen C; Perlmutter JS
    J Neurosurg; 1998 Feb; 88(2):328-30. PubMed ID: 9452245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.